GRANISETRON contains an anti-emetic (eases vomiting symptoms) drug, ‘Granisetron’ that belongs to the class of 5-HT3 receptor antagonists (also called serotonin receptor antagonists or serotonin blockers). It works by blocking the activity of serotonin (chemical messenger) in the brain that triggers nausea and vomiting during cancer treatment (chemotherapy or radiation therapy) or after surgery.
GRANISETRON is available in oral tablet, syrup and intravenous injection formulations. Your doctor will decide the dose and duration based on the severity of your medical condition. Common side effects of GRANISETRON include diarrhoea, constipation, stomach pain, weakness, headache, fever, dizziness, drowsiness, trouble sleeping and anxiety. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.
